15.83London

Friday, 25 October 2024

World No Tobacco Day: Why this lockdown is the best time to quit tobacco

A public awareness drive and better industrial resolve will help to reduce or even stop the use of tobacco products. With the lockdown restrictions in place, if one can manage two to three weeks without smoking, then why not forever? “Today is the best time to quit smoking. People are…

World Multiple Sclerosis Day: All you need to know about the condition

Symptoms of Multiple Sclerosis vary widely, and primarily depend upon which nerves are affected and the amount of damage caused. Those who have severe MS may lose the ability to independently walk while others may suffer from remissions for longer periods without showing any new symptoms. Multiple Sclerosis is a…

New human-mouse chimera is the most human yet

A newly-created mouse-human embryo contains up to 4% human cells — the most human cells yet of any chimera, or an organism made of two different sets of DNA. Surprisingly, those human cells could learn from the mouse cells and develop faster — at the pace of a mouse embryo…

No-Equipment Exercises You Can Do Every Day to Build Upper Body Strength

Many of us know how to build lower-body strength without gym equipment. And we have plenty of at-home core exercises at the ready, too. But when it comes to upper-body workouts, we’re nothing without our dumbbells, our pull-up bars, and our weight machines. No-equipment upper-body exercises don’t come to mind…

Outcomes equal for AYA Hodgkin therapy at peds, adult centers

(HealthDay)—For adolescent and young adult (AYA) patients with Hodgkin lymphoma (HL), treatment strategies differ, but outcomes are equivalent with treatment at pediatric and adult centers, according to a study published online May 22 in Cancer Medicine. Sumit Gupta, M.D., Ph.D., from The Hospital for Sick Children in Toronto, and colleagues…

Tooth loss more prevalent in adults with chronic disease

(HealthDay)—Adults with severe chronic disease or with fair or poor general health have a higher prevalence of edentulism and severe tooth loss, according to research published in the May 29 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Marcia L. Parker, D.M.D., from…

Treatment of chloroquine poisoning

Research by Bangor University’s Professor Dyfrig Hughes has provided important evidence on the safety of treatments that are being tested for use in COVID-19. Chloroquine, an old drug developed for treating malaria, and hydroxychloroquine, a related drug used in autoimmune diseases, are being used as potential treatments for COVID-19. The…